1-(3-CHloro-4-methyl-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid methyl ester

Catalog No. :
ACCSHP673
CAS No. :
345367-42-2
Molecular Formula :
C13H14ClNO3
Molecular Weight :
267.71

IUPAC Name:methyl 1-(3-chloro-4-methylphenyl)-5-oxopyrrolidine-3-carboxylate

1-(3-CHloro-4-methyl-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid methyl ester structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$410.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-CHloro-4-methyl-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid methyl ester
IUPAC Namemethyl 1-(3-chloro-4-methylphenyl)-5-oxopyrrolidine-3-carboxylate
MDL No.MFCD01441280
Molecular FormulaC13H14ClNO3
Molecular Weight267.71
SMILESCOC(C1CN(C2=CC=C(C(Cl)=C2)C)C(C1)=O)=O
InChI KeyOUWJLVKVTUYIJB-UHFFFAOYSA-N
Synonym3-Pyrrolidinecarboxylic acid, 1-(3-chloro-4-methylphenyl)-5-oxo-, methyl ester;1-(3-Chloro-4-methyl-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid methyl ester;Methyl 1-(3-Chloro-4-methylphenyl)-5-oxopyrrolidine-3-carboxylate
CAS No.345367-42-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCSHP673 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTYCQ265 route compound structure diagram
    ACTYCQ26535309-35-4 In Stock
  2. Plus
  3. ACSHZB193 route compound structure diagram
    ACSHZB19389794-02-5 In Stock
  4. Then
  5. ACCSHP673 route product structure diagram
    ACCSHP673345367-42-2
Inquiry

2. ACCSHP673 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCSHP673 route product structure diagram
    ACCSHP673345367-42-2
Inquiry

Comments (0)